Hepatitis C virus infection in the immunocompromised patient.
With this review we have attempted to highlight key issues in the diagnosis and management of HCV infection in immunocompromised patients. Much of the information is preliminary and will require careful assessment with prospective collection of data in large numbers of patients. With the advent of new assays, our ability to diagnose infection is accurate. We are still lacking sufficient data regarding the natural history of infection to aid substantially in the management of these patients. Finally, we desparately need new therapeutic approaches to this disease. Hopefully, with greater understanding of the replication of this virus and the mechanism of liver pathogenicity, novel approaches to treatment will be developed.
Garcia
G
G
Department of Medicine, Stanford University Medical Center, CA 94305-5202.
Terrault
N
N
Wright
T L
TL
D015658:HIV Infections / Q000276:immunology; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D016030:Kidney Transplantation / Q000276:immunology; D017093:Liver Failure / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D015995:Prevalence; D006435:Renal Dialysis